BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38880817)

  • 21. Prognostic Value of the CLIF-C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt.
    Sturm L; Praktiknjo M; Bettinger D; Huber JP; Volkwein L; Schmidt A; Kaeser R; Chang J; Jansen C; Meyer C; Thomas D; Thimme R; Trebicka J; Schultheiß M
    Hepatol Commun; 2021 Apr; 5(4):650-660. PubMed ID: 33860123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.
    Shoreibah MG; Mahmoud K; Aboueldahab NA; Vande Lune P; Massoud M; Bae S; El Khudari H; Gunn AJ; Abdel Aal AK
    J Vasc Interv Radiol; 2019 Feb; 30(2):154-161. PubMed ID: 30717946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
    Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis.
    Zhang Q; Long L; Zhu HL; Peng H; Luo XH; Zhu KS; Wang RP
    World J Gastroenterol; 2023 Nov; 29(42):5768-5780. PubMed ID: 38075849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
    Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.
    Schepke M; Roth F; Fimmers R; Brensing KA; Sudhop T; Schild HH; Sauerbruch T
    Am J Gastroenterol; 2003 May; 98(5):1167-74. PubMed ID: 12809844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.
    Angermayr B; Cejna M; Karnel F; Gschwantler M; Koenig F; Pidlich J; Mendel H; Pichler L; Wichlas M; Kreil A; Schmid M; Ferlitsch A; Lipinski E; Brunner H; Lammer J; Ferenci P; Gangl A; Peck-Radosavljevic M
    Gut; 2003 Jun; 52(6):879-85. PubMed ID: 12740346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.
    Lv Y; Zuo L; Zhu X; Zhao J; Xue H; Jiang Z; Zhuge Y; Zhang C; Sun J; Ding P; Ren W; Li Y; Zhang K; Zhang W; He C; Zhong J; Peng Q; Ma F; Luo J; Zhang M; Wang G; Sun M; Dong J; Bai W; Guo W; Wang Q; Yuan X; Wang Z; Yu T; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Li K; Yin Z; Nie Y; Fan D; Han G
    Gut; 2019 Jul; 68(7):1297-1310. PubMed ID: 30415233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis.
    Wang J; Zhang Z; Yan X; Li M; Xia J; Liu Y; Chen Y; Jia B; Zhu L; Zhu C; Huang R; Wu C
    Dig Liver Dis; 2019 Aug; 51(8):1172-1178. PubMed ID: 30765220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
    Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
    Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
    Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
    Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis.
    Mukund A; Aravind A; Jindal A; Tevethia HV; Patidar Y; Sarin SK
    Dig Dis Sci; 2024 Mar; 69(3):1025-1034. PubMed ID: 38341393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis.
    Wang X; Zhang M; Xiao J; Zhang W; Wang Y; Zhang S; Zou X; Wang L; Zhuge Y; Zhang F
    QJM; 2023 Jun; 116(6):436-442. PubMed ID: 37115637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.
    Zhong BY; Tang HH; Wang WS; Shen J; Zhang S; Li WC; Yin Y; Yang J; Liu F; Ni CF; Zhao JB; Zhu XL
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e153-e160. PubMed ID: 33177378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
    Chapin SE; Goldberg DS; Kaplan DE; Mahmud N
    Dig Dis Sci; 2022 Sep; 67(9):4581-4589. PubMed ID: 34797445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding.
    Conejo I; Guardascione MA; Tandon P; Cachero A; Castellote J; Abraldes JG; Amitrano L; Genescà J; Augustin S
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):132-139.e8. PubMed ID: 28501536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement.
    Allegretti AS; Frenk NE; Li DK; Seethapathy H; Vela Parada XF; Long J; Endres P; Pratt DS; Chung RT; Ganguli S; Irani Z; Yamada K
    PLoS One; 2019; 14(5):e0217442. PubMed ID: 31120995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.